Biotech moves fast. Your CRO should too.

活動詳細資訊:

Meet with Novotech at JPM to discuss accelerated FIH pathways, smarter regional strategies, and global execution designed for biotech momentum.

What we offer biotechs: 

Move faster 

• Start first-in-human (FIH) in Australia without an IND, using established regulatory pathways and experienced local teams.
• Activate sites quickly in high-performing regions so you can reach decision-making data sooner and avoid slow-start bottlenecks. 

Spend smarter 

• Tap capital-efficient regions across APAC and China, where startup, monitoring, and enrollment costs can be significantly lower than in traditional markets.
• Structure studies to balance cost, speed, and quality, ensuring every dollar is focused on reaching your next milestone—not on unnecessary rerouting. 

Scale globally 

• Integrate North America, Europe, and APAC under one coordinated operating model, with consistent governance and communication.
• Benefit from transparent delivery and predictable timelines to support board, partner, and investor discussions. 

If your science is ready to move, we’re ready to help you move faster.